ARCHIVES

Telatinib Demonstrates Positive Results in First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

April 4, 1986

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

Also AACI honors MIT’s Robert Weinberg. Bernard Fisher wins two awards.

November 21, 2003

New Coalition To Lobby for Prevention

November 24, 1978

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987

Cranial Radiation Eliminated With Personalized Chemo

August 28, 2009